5-HT3-Receptor Antagonists and the Cytochrome P450 System: Clinical implications.

Autor: Blower, Peter R.
Předmět:
Zdroj: Cancer Journal; Sep/Oct2002, Vol. 8 Issue 5, p405, 10p, 3 Charts, 1 Graph
Abstrakt: Many patients with cancer receive multiple chemotherapy agents as well as other medications for coexisting medical conditions. Despite the introduction of 5-HT[sub 3] receptor antagonists, the management of nausea and vomiting following cancer treatment and after cancer surgery remains complex, particularly when patients are receiving multiple prescription medications. [ABSTRACT FROM AUTHOR]
Databáze: Supplemental Index